APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Immunology-Oncology Elisa Kits

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Immunology-Oncology Elisa Kits Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173909480326 December 2025191 pages

Choose your research edition.

Industry ResearchImmunology-Oncology Elisa Kits Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Immunology-Oncology Elisa Kits Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Immunology-Oncology Elisa Kits Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immunology-Oncology Elisa Kits Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Immunology-Oncology Elisa Kits Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Immunology-Oncology Elisa Kits market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Immunology-Oncology Elisa Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Immunology-Oncology Elisa Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immunology-Oncology Elisa Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Immunology-Oncology Elisa Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Immunology-Oncology Elisa Kits include Thermo Fisher Scientific, MilliporeSigma (Merck KGaA), RayBiotech Life, Inc., Enzo Life Sciences, ELISAGEN Biotech, Creative Diagnostics, Bio-Techne Corporation (R&D Systems), BioLegend (part of PerkinElmer) and BD Biosciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Immunology-Oncology Elisa Kits market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Immunology-Oncology Elisa Kits and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Immunology-Oncology Elisa Kits sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Immunology-Oncology Elisa Kits market size, projected growth trends, production technologies, key applications, and end-use industries.

Immunology-Oncology Elisa Kits Segment by Company

Thermo Fisher Scientific

MilliporeSigma (Merck KGaA)

RayBiotech Life, Inc.

Enzo Life Sciences

ELISAGEN Biotech

Creative Diagnostics

Bio-Techne Corporation (R&D Systems)

BioLegend (part of PerkinElmer)

BD Biosciences

Abcam

Immunology-Oncology Elisa Kits Segment by Type

Direct ELISA Kit

Indirect ELISA Kit

Immunology-Oncology Elisa Kits Segment by Application

Cancer Diagnosis

Pharmaceutical Industry

Other

Immunology-Oncology Elisa Kits Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunology-Oncology Elisa Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immunology-Oncology Elisa Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunology-Oncology Elisa Kits.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Immunology-Oncology Elisa Kits market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Immunology-Oncology Elisa Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Immunology-Oncology Elisa Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Immunology-Oncology Elisa Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Immunology-Oncology Elisa Kits Industry Trends Table 2. Immunology-Oncology Elisa Kits Industry Drivers Table 3. Immunology-Oncology Elisa Kits Industry Opportunities and Challenges Table 4. Immunology-Oncology Elisa Kits Industry Restraints Table 5. Global Immunology-Oncology Elisa Kits Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Immunology-Oncology Elisa Kits Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Immunology-Oncology Elisa Kits Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Immunology-Oncology Elisa Kits Sales Market Share by Manufacturers Table 9. Global Immunology-Oncology Elisa Kits Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Immunology-Oncology Elisa Kits Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Immunology-Oncology Elisa Kits Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Immunology-Oncology Elisa Kits Manufacturers, Product Type & Application Table 13. Global Immunology-Oncology Elisa Kits Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Immunology-Oncology Elisa Kits by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Direct ELISA Kit Table 17. Major Manufacturers of Indirect ELISA Kit Table 18. Global Immunology-Oncology Elisa Kits Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Immunology-Oncology Elisa Kits Sales by Type (2021-2026) & (K Units) Table 20. Global Immunology-Oncology Elisa Kits Sales by Type (2027-2032) & (K Units) Table 21. Global Immunology-Oncology Elisa Kits Sales Market Share by Type (2021-2026) Table 22. Global Immunology-Oncology Elisa Kits Sales Market Share by Type (2027-2032) Table 23. Global Immunology-Oncology Elisa Kits Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Immunology-Oncology Elisa Kits Revenue by Type (2021-2026) & (K Units) Table 25. Global Immunology-Oncology Elisa Kits Revenue by Type (2027-2032) & (K Units) Table 26. Global Immunology-Oncology Elisa Kits Revenue Market Share by Type (2021-2026) Table 27. Global Immunology-Oncology Elisa Kits Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Cancer Diagnosis Table 29. Major Manufacturers of Pharmaceutical Industry Table 30. Major Manufacturers of Other Table 31. Global Immunology-Oncology Elisa Kits Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Immunology-Oncology Elisa Kits Sales by Application (2021-2026) & (K Units) Table 33. Global Immunology-Oncology Elisa Kits Sales by Application (2027-2032) & (K Units) Table 34. Global Immunology-Oncology Elisa Kits Sales Market Share by Application (2021-2026) Table 35. Global Immunology-Oncology Elisa Kits Sales Market Share by Application (2027-2032) Table 36. Global Immunology-Oncology Elisa Kits Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Immunology-Oncology Elisa Kits Revenue by Application (2021-2026) & (K Units) Table 38. Global Immunology-Oncology Elisa Kits Revenue by Application (2027-2032) & (K Units) Table 39. Global Immunology-Oncology Elisa Kits Revenue Market Share by Application (2021-2026) Table 40. Global Immunology-Oncology Elisa Kits Revenue Market Share by Application (2027-2032) Table 41. Global Immunology-Oncology Elisa Kits Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Immunology-Oncology Elisa Kits Sales by Region (2021-2026) & (K Units) Table 43. Global Immunology-Oncology Elisa Kits Sales Market Share by Region (2021-2026) Table 44. Global Immunology-Oncology Elisa Kits Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Immunology-Oncology Elisa Kits Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Immunology-Oncology Elisa Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Immunology-Oncology Elisa Kits Sales by Country (2021-2026) & (K Units) Table 48. North America Immunology-Oncology Elisa Kits Sales by Country (2027-2032) & (K Units) Table 49. Europe Immunology-Oncology Elisa Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Immunology-Oncology Elisa Kits Sales by Country (2021-2026) & (K Units) Table 51. Europe Immunology-Oncology Elisa Kits Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Immunology-Oncology Elisa Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Immunology-Oncology Elisa Kits Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Immunology-Oncology Elisa Kits Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Immunology-Oncology Elisa Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Immunology-Oncology Elisa Kits Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Immunology-Oncology Elisa Kits Sales by Country (2027-2032) & (K Units) Table 58. Global Immunology-Oncology Elisa Kits Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Immunology-Oncology Elisa Kits Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Immunology-Oncology Elisa Kits Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Immunology-Oncology Elisa Kits Revenue Market Share by Region (2021-2026) Table 62. Global Immunology-Oncology Elisa Kits Revenue Market Share by Region (2027-2032) Table 63. Thermo Fisher Scientific Company Information Table 64. Thermo Fisher Scientific Business Overview Table 65. Thermo Fisher Scientific Immunology-Oncology Elisa Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Thermo Fisher Scientific Immunology-Oncology Elisa Kits Product Portfolio Table 67. Thermo Fisher Scientific Recent Development Table 68. MilliporeSigma (Merck KGaA) Company Information Table 69. MilliporeSigma (Merck KGaA) Business Overview Table 70. MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Product Portfolio Table 72. MilliporeSigma (Merck KGaA) Recent Development Table 73. RayBiotech Life, Inc. Company Information Table 74. RayBiotech Life, Inc. Business Overview Table 75. RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Product Portfolio Table 77. RayBiotech Life, Inc. Recent Development Table 78. Enzo Life Sciences Company Information Table 79. Enzo Life Sciences Business Overview Table 80. Enzo Life Sciences Immunology-Oncology Elisa Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Enzo Life Sciences Immunology-Oncology Elisa Kits Product Portfolio Table 82. Enzo Life Sciences Recent Development Table 83. ELISAGEN Biotech Company Information Table 84. ELISAGEN Biotech Business Overview Table 85. ELISAGEN Biotech Immunology-Oncology Elisa Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. ELISAGEN Biotech Immunology-Oncology Elisa Kits Product Portfolio Table 87. ELISAGEN Biotech Recent Development Table 88. Creative Diagnostics Company Information Table 89. Creative Diagnostics Business Overview Table 90. Creative Diagnostics Immunology-Oncology Elisa Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Creative Diagnostics Immunology-Oncology Elisa Kits Product Portfolio Table 92. Creative Diagnostics Recent Development Table 93. Bio-Techne Corporation (R&D Systems) Company Information Table 94. Bio-Techne Corporation (R&D Systems) Business Overview Table 95. Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Product Portfolio Table 97. Bio-Techne Corporation (R&D Systems) Recent Development Table 98. BioLegend (part of PerkinElmer) Company Information Table 99. BioLegend (part of PerkinElmer) Business Overview Table 100. BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Product Portfolio Table 102. BioLegend (part of PerkinElmer) Recent Development Table 103. BD Biosciences Company Information Table 104. BD Biosciences Business Overview Table 105. BD Biosciences Immunology-Oncology Elisa Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. BD Biosciences Immunology-Oncology Elisa Kits Product Portfolio Table 107. BD Biosciences Recent Development Table 108. Abcam Company Information Table 109. Abcam Business Overview Table 110. Abcam Immunology-Oncology Elisa Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Abcam Immunology-Oncology Elisa Kits Product Portfolio Table 112. Abcam Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Immunology-Oncology Elisa Kits Distributors List Table 116. Immunology-Oncology Elisa Kits Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Immunology-Oncology Elisa Kits Product Image Figure 2. Global Immunology-Oncology Elisa Kits Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immunology-Oncology Elisa Kits Market Size (2021-2032) & (US$ Million) Figure 4. Global Immunology-Oncology Elisa Kits Sales (2021-2032) & (K Units) Figure 5. Global Immunology-Oncology Elisa Kits Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Immunology-Oncology Elisa Kits Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Direct ELISA Kit Image Figure 9. Indirect ELISA Kit Image Figure 10. Global Immunology-Oncology Elisa Kits Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Immunology-Oncology Elisa Kits Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Immunology-Oncology Elisa Kits Sales Market Share by Type (2021-2032) Figure 13. Global Immunology-Oncology Elisa Kits Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Immunology-Oncology Elisa Kits Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Immunology-Oncology Elisa Kits Revenue Market Share by Type (2021-2032) Figure 16. Cancer Diagnosis Image Figure 17. Pharmaceutical Industry Image Figure 18. Other Image Figure 19. Global Immunology-Oncology Elisa Kits Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Immunology-Oncology Elisa Kits Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Immunology-Oncology Elisa Kits Sales Market Share by Application (2021-2032) Figure 22. Global Immunology-Oncology Elisa Kits Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Immunology-Oncology Elisa Kits Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Immunology-Oncology Elisa Kits Revenue Market Share by Application (2021-2032) Figure 25. North America Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Immunology-Oncology Elisa Kits Sales Market Share by Country (2021-2032) Figure 27. U.S. Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Immunology-Oncology Elisa Kits Sales Market Share by Country (2021-2032) Figure 32. Germany Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Immunology-Oncology Elisa Kits Sales Market Share by Country (2021-2032) Figure 39. China Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Immunology-Oncology Elisa Kits Sales Market Share by Country (2021-2032) Figure 47. Brazil Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Immunology-Oncology Elisa Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Immunology-Oncology Elisa Kits Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Immunology-Oncology Elisa Kits Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Figure 58. North America Immunology-Oncology Elisa Kits Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Figure 60. Europe Immunology-Oncology Elisa Kits Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Immunology-Oncology Elisa Kits Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Immunology-Oncology Elisa Kits Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Immunology-Oncology Elisa Kits Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Immunology-Oncology Elisa Kits Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Direct ELISA Kit
  • Indirect ELISA Kit
Applications
  • Cancer Diagnosis
  • Pharmaceutical Industry
  • Other
Companies covered
  • Thermo Fisher Scientific
  • MilliporeSigma (Merck KGaA)
  • RayBiotech Life, Inc.
  • Enzo Life Sciences
  • ELISAGEN Biotech
  • Creative Diagnostics
  • Bio-Techne Corporation (R&D Systems)
  • BioLegend (part of PerkinElmer)
  • BD Biosciences
  • Abcam

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Immunology-Oncology Elisa Kits Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Immunology-Oncology Elisa Kits Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Immunology-Oncology Elisa Kits Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Immunology-Oncology Elisa Kits Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Immunology-Oncology Elisa Kits Market Dynamics
  1. 2.1 Immunology-Oncology Elisa Kits Industry Trends
  2. 2.2 Immunology-Oncology Elisa Kits Industry Drivers
  3. 2.3 Immunology-Oncology Elisa Kits Industry Opportunities and Challenges
  4. 2.4 Immunology-Oncology Elisa Kits Industry Restraints
3 Immunology-Oncology Elisa Kits Market by Manufacturers
  1. 3.1 Global Immunology-Oncology Elisa Kits Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Immunology-Oncology Elisa Kits Sales by Manufacturers (2021-2026)
  3. 3.3 Global Immunology-Oncology Elisa Kits Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Immunology-Oncology Elisa Kits Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Immunology-Oncology Elisa Kits Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Immunology-Oncology Elisa Kits Manufacturers, Product Type & Application
  7. 3.7 Global Immunology-Oncology Elisa Kits Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Immunology-Oncology Elisa Kits Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Immunology-Oncology Elisa Kits Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Immunology-Oncology Elisa Kits Tier 1, Tier 2, and Tier 3
4 Immunology-Oncology Elisa Kits Market by Type
  1. 4.1 Immunology-Oncology Elisa Kits Type Introduction
  2. 4.1.1 Direct ELISA Kit
  3. 4.1.2 Indirect ELISA Kit
  4. 4.2 Global Immunology-Oncology Elisa Kits Sales by Type
  5. 4.2.1 Global Immunology-Oncology Elisa Kits Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Immunology-Oncology Elisa Kits Sales by Type (2021-2032)
  7. 4.2.3 Global Immunology-Oncology Elisa Kits Sales Market Share by Type (2021-2032)
  8. 4.3 Global Immunology-Oncology Elisa Kits Revenue by Type
  9. 4.3.1 Global Immunology-Oncology Elisa Kits Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Immunology-Oncology Elisa Kits Revenue by Type (2021-2032)
  11. 4.3.3 Global Immunology-Oncology Elisa Kits Revenue Market Share by Type (2021-2032)
5 Immunology-Oncology Elisa Kits Market by Application
  1. 5.1 Immunology-Oncology Elisa Kits Application Introduction
  2. 5.1.1 Cancer Diagnosis
  3. 5.1.2 Pharmaceutical Industry
  4. 5.1.3 Other
  5. 5.2 Global Immunology-Oncology Elisa Kits Sales by Application
  6. 5.2.1 Global Immunology-Oncology Elisa Kits Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Immunology-Oncology Elisa Kits Sales by Application (2021-2032)
  8. 5.2.3 Global Immunology-Oncology Elisa Kits Sales Market Share by Application (2021-2032)
  9. 5.3 Global Immunology-Oncology Elisa Kits Revenue by Application
  10. 5.3.1 Global Immunology-Oncology Elisa Kits Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Immunology-Oncology Elisa Kits Revenue by Application (2021-2032)
  12. 5.3.3 Global Immunology-Oncology Elisa Kits Revenue Market Share by Application (2021-2032)
6 Global Immunology-Oncology Elisa Kits Sales by Region
  1. 6.1 Global Immunology-Oncology Elisa Kits Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Immunology-Oncology Elisa Kits Sales by Region (2021-2032)
  3. 6.2.1 Global Immunology-Oncology Elisa Kits Sales by Region (2021-2026)
  4. 6.2.2 Global Immunology-Oncology Elisa Kits Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Immunology-Oncology Elisa Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Immunology-Oncology Elisa Kits Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Immunology-Oncology Elisa Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Immunology-Oncology Elisa Kits Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Immunology-Oncology Elisa Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Immunology-Oncology Elisa Kits Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Immunology-Oncology Elisa Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Immunology-Oncology Elisa Kits Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Immunology-Oncology Elisa Kits Revenue by Region
  1. 7.1 Global Immunology-Oncology Elisa Kits Revenue by Region
  2. 7.1.1 Global Immunology-Oncology Elisa Kits Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Immunology-Oncology Elisa Kits Revenue by Region (2021-2026)
  4. 7.1.3 Global Immunology-Oncology Elisa Kits Revenue by Region (2027-2032)
  5. 7.1.4 Global Immunology-Oncology Elisa Kits Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Immunology-Oncology Elisa Kits Revenue (2021-2032)
  8. 7.2.2 North America Immunology-Oncology Elisa Kits Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Immunology-Oncology Elisa Kits Revenue (2021-2032)
  11. 7.3.2 Europe Immunology-Oncology Elisa Kits Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Immunology-Oncology Elisa Kits Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Immunology-Oncology Elisa Kits Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Immunology-Oncology Elisa Kits Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Immunology-Oncology Elisa Kits Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Immunology-Oncology Elisa Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Immunology-Oncology Elisa Kits Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 MilliporeSigma (Merck KGaA)
  8. 8.2.1 MilliporeSigma (Merck KGaA) Company Information
  9. 8.2.2 MilliporeSigma (Merck KGaA) Business Overview
  10. 8.2.3 MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Product Portfolio
  12. 8.2.5 MilliporeSigma (Merck KGaA) Recent Developments
  13. 8.3 RayBiotech Life, Inc.
  14. 8.3.1 RayBiotech Life, Inc. Company Information
  15. 8.3.2 RayBiotech Life, Inc. Business Overview
  16. 8.3.3 RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Product Portfolio
  18. 8.3.5 RayBiotech Life, Inc. Recent Developments
  19. 8.4 Enzo Life Sciences
  20. 8.4.1 Enzo Life Sciences Company Information
  21. 8.4.2 Enzo Life Sciences Business Overview
  22. 8.4.3 Enzo Life Sciences Immunology-Oncology Elisa Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Enzo Life Sciences Immunology-Oncology Elisa Kits Product Portfolio
  24. 8.4.5 Enzo Life Sciences Recent Developments
  25. 8.5 ELISAGEN Biotech
  26. 8.5.1 ELISAGEN Biotech Company Information
  27. 8.5.2 ELISAGEN Biotech Business Overview
  28. 8.5.3 ELISAGEN Biotech Immunology-Oncology Elisa Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ELISAGEN Biotech Immunology-Oncology Elisa Kits Product Portfolio
  30. 8.5.5 ELISAGEN Biotech Recent Developments
  31. 8.6 Creative Diagnostics
  32. 8.6.1 Creative Diagnostics Company Information
  33. 8.6.2 Creative Diagnostics Business Overview
  34. 8.6.3 Creative Diagnostics Immunology-Oncology Elisa Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Creative Diagnostics Immunology-Oncology Elisa Kits Product Portfolio
  36. 8.6.5 Creative Diagnostics Recent Developments
  37. 8.7 Bio-Techne Corporation (R&D Systems)
  38. 8.7.1 Bio-Techne Corporation (R&D Systems) Company Information
  39. 8.7.2 Bio-Techne Corporation (R&D Systems) Business Overview
  40. 8.7.3 Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Product Portfolio
  42. 8.7.5 Bio-Techne Corporation (R&D Systems) Recent Developments
  43. 8.8 BioLegend (part of PerkinElmer)
  44. 8.8.1 BioLegend (part of PerkinElmer) Company Information
  45. 8.8.2 BioLegend (part of PerkinElmer) Business Overview
  46. 8.8.3 BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Product Portfolio
  48. 8.8.5 BioLegend (part of PerkinElmer) Recent Developments
  49. 8.9 BD Biosciences
  50. 8.9.1 BD Biosciences Company Information
  51. 8.9.2 BD Biosciences Business Overview
  52. 8.9.3 BD Biosciences Immunology-Oncology Elisa Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BD Biosciences Immunology-Oncology Elisa Kits Product Portfolio
  54. 8.9.5 BD Biosciences Recent Developments
  55. 8.10 Abcam
  56. 8.10.1 Abcam Company Information
  57. 8.10.2 Abcam Business Overview
  58. 8.10.3 Abcam Immunology-Oncology Elisa Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Abcam Immunology-Oncology Elisa Kits Product Portfolio
  60. 8.10.5 Abcam Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Immunology-Oncology Elisa Kits Value Chain Analysis
  2. 9.1.1 Immunology-Oncology Elisa Kits Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Immunology-Oncology Elisa Kits Production Mode & Process
  6. 9.2 Immunology-Oncology Elisa Kits Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Immunology-Oncology Elisa Kits Distributors
  9. 9.2.3 Immunology-Oncology Elisa Kits Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst